Supporting this, Liu et al. demonstrated that treatment with simvastatin has been shown to inhibit protein prenylation in breast cancer cells, leading to decreased IL-6 secretion and reduced proliferation of senescent conditioned media on breast cancer cells [220]. The gene discussed is IL6; the disease is breast carcinoma.